Package 67046-1641-3

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 67046-1641-3
Digits Only 6704616413
Product NDC 67046-1641
Product ID 67046-1641_47b96885-2003-29c2-e063-6294a90a2a35
Description

30 TABLET, FILM COATED in 1 BLISTER PACK (67046-1641-3)

Marketing

Marketing Status
Marketed Since 2026-01-06
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "47b96885-2003-29c2-e063-6294a90a2a35", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993691"], "spl_set_id": ["47b96919-a8ea-b769-e063-6394a90aa34e"], "manufacturer_name": ["Coupler LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (67046-1641-3)", "package_ndc": "67046-1641-3", "marketing_start_date": "20260106"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "67046-1641_47b96885-2003-29c2-e063-6294a90a2a35", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "67046-1641", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Coupler LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "75 mg/1"}], "application_number": "ANDA075491", "marketing_category": "ANDA", "marketing_start_date": "20260106", "listing_expiration_date": "20271231"}